Online citations, reference lists, and bibliographies.
← Back to Search

PPARalpha And PPARgamma Activators Direct A Distinct Tissue‐specific Transcriptional Response Via A PPRE In The Lipoprotein Lipase Gene.

K. Schoonjans, J. Peinado-Onsurbe, A. Lefebvre, R. A. Heyman, M. Briggs, S. Deeb, B. Staels, J. Auwerx
Published 1996 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Increased activity of lipoprotein lipase (LPL) may explain the hypotriglyceridemic effects of fibrates, thiazolidinediones and fatty acids, which are known activators (and/or ligands) of the various peroxisome proliferator‐activated receptors (PPARs). Treatment with compounds which activate preferentially PPARalpha, such as fenofibrate, induced LPL expression exclusively in rat liver. In contrast, the antidiabetic thiazolidinedione BRL 49653, a high affinity ligand for PPARgamma, had no effect on liver, but induced LPL expression in rat adipose tissue. In the hepatocyte cell line AML‐12, fenofibric acid, but not BRL 49653, induced LPL mRNA, whereas in 3T3‐L1 preadipocytes, the PPARgamma ligand induced LPL mRNA levels much quicker and to a higher extent than fenofibric acid. In both the in vivo and in vitro studies, inducibility by either PPARalpha or gamma activators, correlated with the tissue distribution of the respective PPARs: an adipocyte‐restricted expression of PPARgamma, whereas PPARalpha was expressed predominantly in liver. A sequence element was identified in the human LPL promoter that mediates the functional responsiveness to fibrates and thiazolidinediones. Methylation interference and gel retardation assays demonstrated that a PPARalpha or gamma and the 9‐cis retinoic acid receptor (RXR) heterodimers bind to this sequence −169 TGCCCTTTCCCCC −157. These data provide evidence that transcriptional activation of the LPL gene by fibrates and thiazolidinediones is mediated by PPAR‐RXR heterodimers and contributes significantly to their hypotriglyceridemic effects in vivo. Whereas thiazolidinediones predominantly affect adipocyte LPL production through activation of PPARgamma, fibrates exert their effects mainly in the liver via activation of PPARalpha.
This paper references
The effects of fibrates on lipoprotein and hemostatic risk factors
G. Schonfeld (1994)
10.1146/ANNUREV.PA.29.040189.001045
Biochemical mechanisms of induction of hepatic peroxisome proliferation.
E. Lock (1989)
10.1073/PNAS.91.5.1786
Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival.
A. Chawla (1994)
Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression.
E. Amri (1991)
10.1021/BI00436A001
Structure of the human lipoprotein lipase gene.
S. Deeb (1989)
10.1016/0014-5793(93)80200-E
Developmental extinction of liver lipoprotein lipase mRNA expression might be regulated by an NF‐1‐like site
K. Schoonjans (1993)
Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids.
J. C. Rodríguez (1994)
PPARy2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
P. Tontonoz (1995)
Purification. cloning, and RXR identity
M Leid (1992)
10.1074/JBC.270.33.19269
Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter (*)
K. Schoonjans (1995)
10.1073/PNAS.91.23.11012
The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression.
T. Gulick (1994)
CairaT.. Moore.D.D. and Kelly.D.P
T. Gulick (1994)
Differential Expression of Peroxisome Proliferator-Activated Receptors ( PPARs ) : Tissue Distribution of PPAR-a , $ 3 , andy in the Adult Rat *
Olivier
10.5282/UBM/EPUB.9875
Where is the mouse
F. Klippel (1990)
10.1056/NEJM199109263251307
Insulin resistance--mechanisms, syndromes, and implications.
D. Moller (1991)
Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms.
R. Distel (1992)
Cloning and characterization of the murine lipoprotein lipase - encoding gene : structural and functional analysis
ShimuraY. (1991)
Antidiabetic AD 4743 enhances adipocyte differentiation of 3 T 3 T mesenchymal stem cells
J. Auwerx (1991)
Differential activation of peroxisome
M. Brown (1995)
10.1016/S0140-6736(63)91500-9
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
P. Randle (1963)
10.1093/NAR/10.24.7895
Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.
P. Masiakowski (1982)
10.1073/PNAS.92.21.9856
Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha.
E. Hu (1995)
Differential expression and activation of a family of murine peroxisome proliferator - activzated receptors
M. Lehman.J. (1994)
10.1073/PNAS.75.12.6054
Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones.
R. Négrel (1978)
10.1073/PNAS.90.6.2160
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.
H. Keller (1993)
10.1016/S0248-4900(05)80176-5
Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)
C. Dreyer (1993)
10.1016/0026-0495(86)90125-3
Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects.
A. Gnasso (1986)
Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter.
C. Palmer (1994)
Effects of procetofen on serum
D. Sommariva (1983)
10.1172/JCI118118
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
N. Vu-dac (1995)
Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.
H. De Silva (1994)
Overexpression of human
H. V. de Silva (1994)
10.1073/PNAS.89.10.4653
Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.
M. Göttlicher (1992)
10.3109/10408369209114602
Lipoprotein lipase: recent contributions from molecular biology.
J. Auwerx (1992)
Dietary influences on serum lipids
S. M. Grundy (1990)
10.1210/MEND.6.10.1333051
Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.
A. Schmidt (1992)
Isolation and characterization of the hamster peroxisomal proliferator activated receptor hPPARy , a member of the nuclear hormone receptor superfamily
J. Auwerx (1995)
10.1074/JBC.271.16.9455
Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice (*)
B. Zhang (1996)
10.1002/JCP.1041340115
Preadipocyte differentiation in vitro: Identification of a highly active adipogenic agent
A. Hiragun (1988)
10.1093/nar/15.13.5490
CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements
B. Luckow (1987)
Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and alpha-fetoprotein as models.
B. Staels (1992)
Effects of clofibrate. bezafibrate
F. Heller (1983)
The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid.
A. S. Muerhoff (1992)
An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
K. Alvares (1994)
Establishment and characterization of differentiated nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor ot
K. Yu (1994)
Fibrates down-regulate apolipoprotein C-1Il expression independent of induction of peroxisomal acyl co-enzyme A
B. Staels (1995)
10.1002/j.1460-2075.1995.tb00147.x
Inhibition of adipogenesis by the stress‐induced protein CHOP (Gadd153).
N. Batchvarova (1995)
10.1074/jbc.270.41.23975
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (*)
K. Yu (1995)
Two cis - acting regulatory elements in the peroxisome proliferator - responsive element enhancer region of rat acyl - CoA oxidase gene
E. F. Johnson (1991)
10.1073/PNAS.90.12.5723
Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression.
S. Marcus (1993)
10.1042/BJ2570389
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells.
D. Gaillard (1989)
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
Y. Zhu (1993)
Youkhana.K. and Gimble.J.M
HuaX (1991)
10.1074/JBC.270.22.13470
Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.
R. Hertz (1995)
10.1016/0005-2760(91)90089-Z
Metabolic aspects of peroxisomal β-oxidation
H. Osmundsen (1991)
mPPARy 2 : tissue - specific regulator of an adipocyte enhancer
P. Tontonoz
Smith-Oliver,T.A.. Wilkison,W.O., Willson.T.M. and Kliewer.S.A
J. M. Lehmann (1995)
Antidiabetic AD4743 enhances
R. L. Sparks (1991)
10.1093/nar/11.1.141
CAP and RNA polymerase interactions with the lac promoter: binding stoichiometry and long range effects
M. Fried (1983)
10.1098/rspb.1992.0012
The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat
F. Beck (1992)
10.1006/BBRC.1993.1378
PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene.
O. Bardot (1993)
10.1152/AJPCELL.1993.264.6.C1600
Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells.
T. Sandouk (1993)
10.1016/0092-8674(95)90194-9
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
S. Kliewer (1995)
10.1172/JCI116066
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
K. Aalto-Setälä (1992)
cDNA clonina, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor
T. Sher (1993)
Rachubinski.R.A. and Capone.J.P
Zhang.B (1993)
10.1097/00007611-199509000-00001
Severe obesity: expensive to society, frustrating to treat, but important to confront.
L. F. Martin (1995)
Acyl-CoA synthetase mRNA
K. Schoonjans (1993)
10.1074/JBC.270.47.28183
Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like Cells (*)
L. Teboul (1995)
Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
N. Vu-dac (1994)
10.1021/BI00437A009
Lipoprotein lipase gene expression in THP-1 cells.
J. Auwerx (1989)
10.1172/JCI110542
Effects of dietary cholesterol and fatty acids on plasma lipoproteins.
G. Schonfeld (1982)
Differential expression of peroxisome proliferator-activated receptors: tissue
O. Braissant (1995)
10.1074/JBC.270.22.12953
An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)
J. Lehmann (1995)
10.1093/AJCN/57.6.922
Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.
E. Levy (1993)
10.1007/BF00544015
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects
F. Heller (2004)
10.1172/JCI111711
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
C. Wang (1985)
Effects of procetofen on seum serum lipids and lipoproteins and on plasma post-heparin lipase activities in type II and in type IV hyperlipoproteinemic patients
D. Sommariva (1983)
10.1172/JCI118041
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.
T. Buchanan (1995)
Thiazolidinediones repress oh gene expression via activation of PPARy
P Vos (1996)
10.1074/JBC.270.13.7724
Thiazolidine Derivatives Ameliorate High Glucose-induced Insulin Resistance via the Normalization of Protein-tyrosine Phosphatase Activities (*)
H. Maegawa (1995)
10.1111/J.1432-1033.1993.TB18181.X
Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation.
K. Schoonjans (1993)
10.1016/0092-8674(92)90478-U
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently
M. Leid (1992)
Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
R. Kletzien (1992)
10.1002/j.1460-2075.1992.tb05072.x
The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.
J. Tugwood (1992)
15-Deoxy-A12.14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARY
B M Spiegelman (1995)
10.1038/347645A0
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
I. Issemann (1990)
10.1073/PNAS.89.16.7541
Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase.
B. Zhang (1992)
10.1016/0092-8674(94)90006-X
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
P. Tontonoz (1994)
10.1074/JBC.270.5.2367
Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes
E. Amri (1995)
10.1042/BJ2320229
Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart.
I. Ramírez (1985)
10.1016/0026-0495(89)90086-3
Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
P. Weisweiler (1989)
Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
H. Ikeda (1990)
CAT constructions with multiple unique
B. Luckow (1987)
Syndromes of insulin resistance and mutant insulin
J. DeGroot.L. (1995)
Control of the peroxisomal 3 - oxidation pathway by a novel family of nuclear hormone receptors
C.. Keller Dreyer (1992)
Dietary influences on serum lipids and lipoproteins.
S. Grundy (1990)
10.1101/GAD.10.8.974
Differential activation of adipogenesis by multiple PPAR isoforms.
R. Brun (1996)



This paper is referenced by
10.1128/MCB.22.8.2607-2619.2002
Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux
T. Akiyama (2002)
10.1016/S1040-8428(98)00003-1
Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications.
W. Jiang (1998)
10.1146/ANNUREV.NUTR.19.1.63
Regulation of gene expression by dietary fat.
D. Jump (1999)
10.1016/j.ebiom.2016.09.025
Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis
Yan Gong (2016)
10.1016/S0300-9084(01)01343-8
A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes.
M. Glorian (2001)
Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance.
L. Madsen (2002)
10.1016/S0008-6363(02)00405-4
The pivotal role of lipoprotein lipase in atherosclerosis.
J. R. Mead (2002)
10.1007/s00125-004-1436-1
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin
J.-M. Ye (2004)
Receptory aktywowane przez proliferatory peroksysomów-g (PPAR-g ) oraz ich rola w immunoregulacji i kontroli reakcji zapalnej* Peroxisome proliferator-activated receptors-g (PPAR-g ) and their role in immunoregulation and infl ammation control
M. L. Kowalski (2005)
10.1111/J.1471-4159.2005.03175.X
Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrier.
A. Sovic (2005)
10.1194/JLR.M500203-JLR200
PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
U. Edvardsson (2006)
10.1093/PS/86.6.1187
Effects of clofibrate treatment in laying hens.
B. König (2007)
10.1002/JPS.20973
Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes.
Yan Xu (2007)
10.1155/2008/243791
PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility
Cadence E. Minge (2008)
10.1210/ME.2007-0271
Modulator recognition factor-2 is required for adipogenesis in mouse embryo fibroblasts and 3T3-L1 cells.
Takahiro Yamakawa (2008)
10.2217/17460875.3.2.163
Role of stearoyl-CoA desaturase in human metabolic disease
H. Sampath (2008)
On the importance of fat cell size, location and signaling in insulin resistance
Niclas Franck (2009)
10.1016/j.jnutbio.2008.01.006
Genistein inhibits differentiation of primary human adipocytes.
Hea Jin Park (2009)
10.1155/2009/460764
Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
A. Aljada (2009)
10.1016/j.bbrc.2009.09.017
Activation of AMP-activated protein kinase (AMPK) inhibits fatty acid synthesis in bovine mammary epithelial cells.
J. McFadden (2009)
10.1155/2010/407650
Phytochemicals as Modulators of PPARs and RXRs
J. Ko (2010)
EVALUATING THE ROLE OF PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR GAMA COACTIVATOR-1 ALPHA IN MITOCHONDRIAL BIOGENESIS IN GOLDFISH
Trevor Snider (2013)
10.5604/17322693.1080028
[The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
Małgorzata Chmielewska-Kassassir (2013)
10.1155/2017/1645828
Dietary Oxidized Linoleic Acid Modulates Plasma Lipids beyond Triglycerides Metabolism
Mahdi Garelnabi (2017)
10.1007/s10719-012-9454-6
Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs
Takero Nakajima (2012)
10.1152/ajpregu.00787.2007
Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep.
J. Duffield (2008)
10.1159/000365423
Introduction to fatty acids and lipids.
G. Burdge (2015)
10.1038/sj.ijo.0802641
Conjugated linoleic acid and obesity control: efficacy and mechanisms
Y. Wang (2004)
10.4162/nrp.2012.6.6.499
Resveratrol inhibits the protein expression of transcription factors related adipocyte differentiation and the activity of matrix metalloproteinase in mouse fibroblast 3T3-L1 preadipocytes
Nam E Kang (2012)
Syddansk Universitet RNA-binding protein PSPC 1 promotes the differentiation-dependent nuclear export of adipocyte RNAs
Jiexin Wang (2017)
10.3109/07435800.2013.828741
Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells
Shi Yin (2014)
In silico miRNA Target Identification within the Human Peroxisome Proliferator Gene
Sudip Paul (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar